WAPPS-Hemo is pleased to announce that Altuviiio™ is now available!
We are pleased to announce that the concentrate Altuviiio™ (also named BIVV001), newly approved by FDA, was added on the WAPPS-Hemo platform.
The WAPPS-Hemo Team - Apr 14, 2023
View this WAPPS News Article
The WAPPS-Hemo Team - Jun 13, 2022
View this WAPPS News Article
The WAPPS-Hemo Team - Sep 1, 2020
WAPPS-Hemo is pleased to announce the launch of two new population pharmacokinetic (PK) models for ESPEROCT® (Antihemophilic Factor VIII (Recombinant, B-Domain Truncated), PEGylated) that use the one-stage and chromogenic assays.
The WAPPS-Hemo Team - Jun 11, 2020
Currently available PK models in WAPPS-Hemo. New models are added when sufficient data has been collected.
The WAPPS-Hemo Team - Apr 2, 2020
If you have any WAPPS-Hemo related research or news items you would like to share, please contact us
© 2024 Copyright WAPPS-Hemo